INTRODUCTION {#S1}
============

Mitochondrial Ca^2+^ uptake provides a fundamental input to the control of oxidative metabolism and contributes to cell-survival-regulating mechanisms. It is primarily driven by the membrane potential (ΔΨ~m~) and is mediated by an electrogenic uniport, referred to as "Ca^2+^ uniporter" (mtCU). Tissue-specific differences in the Ca^2+^ uptake kinetics have been noted for some time and attributed to tissue-specific alternative Ca^2+^ up-take mechanisms. These mechanisms either had a phenomenological definition, such as rapid uptake mode, or were linked to ryanodine receptors or uncoupling proteins ([@R4]; [@R8]). Recently, comparison of/~MiCa~ in different tissues revealed great differences in the current density ([@R9]). Among tissues with high amounts of mitochondria that strongly depend on oxidative metabolism, liver, muscle, and heart showed both qualitative and quantitative differences in Ca^2+^ uptake and currents ([@R4]; [@R9]). These differences are particularly interesting in the context of the distinct frequencies of calcium signals that hepatic and cardiac mitochondria cope with. Specifically, in resting hepatocytes, cytoplasmic Ca^2+^ (\[Ca^2+^\]~c~) is steadily low, and upon stimulation, \[Ca^2+^\]~c~ oscillations are induced with a cycle time of 20 s or more ([@R11]; [@R26]). By contrast, in murine cardiomyocytes, \[Ca^2+^\]~c~ constantly oscillate with resting and stimulated cycle times between 0.15 and 0.08 s. In hepatocytes, each \[Ca^2+^\]~c~ spike propagates to mitochondria individually, whereas in mouse cardiomyocytes, mitochondria likely take up little Ca^2+^ from a single \[Ca^2+^\]~c~ spike and integrate spikes of varying frequencies to control the Ca^2+^ response ([@R10]).

The major mtCU-forming proteins have been identified, including the pore, MCU ([@R3]; [@R5]; [@R7]); its dominant-negative form, MCUb ([@R25]); a scaffold, EMRE ([@R28]); and helix-loop-helix structural domain (EF-hand) containing Ca^2+^-sensitive regulators, MICU1 ([@R6]; [@R18]; [@R23]; [@R31]) and MICU2 ([@R13]; [@R22]; [@R24]). To date, a MICU complex (a hetero/homo-dimer of MICU1 and MICU2) appears to determine both the threshold and cooperative activation of the mtCU by Ca^2+^ ([@R6]; [@R12]; [@R22]; [@R23]; [@R24]).

MCU and MICU1 both show tissue-specific mRNA expression, which is particularly low for MICU1 in cardiac muscle ([@R7]; [@R19]; [@R24]). Whole-body MCU knockout is either embryonic lethal or unexpectedly irrelevant for normal development, depending upon the mouse strain ([@R21]). We have shown that MICU1 knockout mice die perinatally, and deletion of MICU1 in the liver interferes with survival and tissue regeneration after partial hepatectomy ([@R2]). Loss-of-function human MICU1 mutations have also been linked to neurological and skeletal muscle disease ([@R15]). MICU1/2 have been shown to account for the non-linear Ca^2+^ dependence of mtCU-mediated Ca^2+^ uptake, but their involvement in the in vivo tissue-specific differences in the mtCU Ca^2+^ sensitivity is still unclear. Here, we tested whether protein levels of MICUs and MCU and their stoichiometry could control mitochondrial Ca^2+^ uptake in accordance with tissue-specific physiological needs. In terms of integration of mitochondrial Ca^2+^ uptake with tissue-specific functions, the control of/~MiCa~ by \[Ca^2+^\]~c~ is highly relevant but is difficult to study at low \[Ca^2+^\]. The lowest \[Ca^2+^\] tested by [@R9] was 50 μM, which is orders of magnitude higher than the resting \[Ca^2+^\]~c~. A recent modeling study emphasized that cardiac and liver mitochondria display a common relationship for the \[Ca^2+^\]~c~ dependence of mitochondrial Ca^2+^ uptake ([@R32]), but the submicromolar range of the curve fit does not seem to be reliable. Therefore, we decided to systematically quantify the \[Ca^2+^\]~c~ dependence of mitochondrial Ca^2+^ fluxes and the uniporter protein constituents in different tissues derived from the same donor mouse.

RESULTS {#S2}
=======

Distinct Ca^2+^ Dependence of Ca^2+^ Uptake and Oxidative Metabolism in Heart and Liver {#S3}
---------------------------------------------------------------------------------------

We first focused on cardiac and liver mitochondria and evaluated mtCU-mediated mitochondrial Ca^2+^ uptake fluorometrically in suspensions of isolated mitochondria by measuring the ruthenium red (RuRed)-sensitive clearance of Ca^2+^ added to the cytoplasmic medium. To better isolate the mitochondrial Ca^2+^ influx, these experiments were done in the presence of sarco/endoplasmic reticulum Ca^2+^-ATPase (SERCA) inhibitor thapsigargin (Tg) and the mitochondrial Na^+^-Ca^2+^ exchanger blocker CGP37157. Interestingly, in response to submicromolar \[Ca^2+^\]~c~ increases, liver mitochondria displayed almost no Ca^2+^ clearance, whereas heart mitochondria showed a strong decrease in \[Ca^2+^\]~c~ ([Figure 1A](#F1){ref-type="fig"}). This suggests that the \[Ca^2+^\] threshold of the mtCU can be very low for certain tissues, such as heart.

To assess a potential effect on oxidative metabolism, we evaluated the NAD(P)H autofluorescence as a measure of the activation of the Ca^2+^-sensitive matrix dehydrogenases. The Ca^2+^ uptake observed at low \[Ca^2+^\]~c~ in heart mitochondria was associated with a significant increase in NAD(P)H, whereas no changes in NAD(P)H were observed in liver mitochondria under the same conditions ([Figure 1B](#F1){ref-type="fig"}). When exposed to higher free \[Ca^2+^\]~c~ up to 15 μM, a rapid mitochondrial Ca^2+^ clearance was measured for both tissues, with liver mitochondria taking up Ca^2+^ faster than heart mitochondria ([Figure 1C](#F1){ref-type="fig"}). Simultaneous recordings of \[Ca^2+^\]~c~ and ΔΨ~m~ showed only small depolarization during Ca^2+^ uptake in cardiac mitochondria, indicating that the uptake was not limited by the driving force ([Figure 1D](#F1){ref-type="fig"}). At this higher \[Ca^2+^\]~c~ exposure, NAD(P)H response was higher in liver mitochondria than heart mitochondria ([Figure 1B](#F1){ref-type="fig"}; 8.03% ± 1.06% in liver versus 3.27% ± 0.90% in heart; p \< 0.05). Both the mitochondrial depolarization and the NAD(P)H response to Ca^2+^ were prevented by RuRed (n = 3; data not shown), confirming that these changes were downstream of mitochondrial Ca^2+^ uptake.

To better characterize the \[Ca^2+^\]~c~ dependence of the hepatic and cardiac mitochondrial Ca^2+^ uptake, we constructed a \[Ca^2+^\]~c~ dose response for the initial Ca^2+^ uptake rates ([Figure S1](#SD1){ref-type="supplementary-material"}) and for the fractional uptake ([Figure 1E](#F1){ref-type="fig"}). In both presentations, the low end reached lower and the high end higher values for liver mitochondria, suggesting a higher mtCU \[Ca^2+^\]~c~ threshold and higher maximal activity. Double logarithmic plots of the initial Ca^2+^ uptake rates against \[Ca^2+^\]~c~ confirmed a higher slope in liver than in heart ([Figure 1F](#F1){ref-type="fig"}; 2.67 ± 0.09 versus 1.48 ± 0.12; p \< 0.05). Thus, mitochondrial Ca^2+^ uptake displays distinct Ca^2+^ dependence between heart and liver and occurs already at submicromolar \[Ca^2+^\]~c~ in heart mitochondria.

Liver, Heart, and Muscle Mitochondria Show Differential Activation of Mitochondrial Ca^2+^ Uptake by Ca^2+^, Linked to Their Distinct MICUs and MCU Expression Profiles {#S4}
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------

To further address the regulation of the mtCU in different tissues, we quantified the RuRed-sensitive ^45^Ca^2+^ (^45^Ca) sequestration by mitochondria isolated from heart, liver, and skeletal muscle. In response to a submicromolar Ca^2+^ bolus (660 nM), liver mitochondria displayed linear uptake kinetic for at least 30 s with a hardly detectable rate, whereas cardiac and even more the skeletal muscle mitochondria showed faster ^45^Ca accumulation ([Figures 2A](#F2){ref-type="fig"} and [2C](#F2){ref-type="fig"}), demonstrating a very low threshold of activation for the mtCU in the latter tissues. Differently, in response to 12 μM \[Ca^2+^\], ^45^Ca uptake by liver mitochondria was faster than that by heart mitochondria, whereas uptake by skeletal muscle mitochondria was the fastest ([Figures 2B](#F2){ref-type="fig"} and [2C](#F2){ref-type="fig"}). RuRed effectively abolished ^45^Ca accumulation by mitochondria isolated from each tissue, validating the specificity of the uptake through the mtCU. Double logarithmic plots of the initial Ca^2+^ accumulation (15 s; RuRed sensitive uptake) against \[Ca^2+^\]~c~ indicated a higher threshold for liver than heart or skeletal muscle mitochondria ([Figure 2D](#F2){ref-type="fig"}). The plot for liver mitochondria also showed a higher slope, confirming different levels of positive cooperativity for \[Ca^2+^\]-dependent activation of mtCU in the different tissues (liver: 1.68 versus heart: 1.02 and muscle: 0.87; p \< 0.05), as shown by fluorescence ([Figure 1F](#F1){ref-type="fig"}).

We speculated that the relative abundance of MICUs and MCU proteins might account for the tissue-specific mitochondrial Ca^2+^ uptake phenotypes in these three tissues. Analysis of the protein level of the components of the mtCU in the mitochondria used for the Ca^2+^ transport measurements showed higher MICU1 abundance in mouse liver and skeletal muscle versus heart mitochondria, whereas MICU2 appeared relatively high in heart mitochondria. MCU was slightly but significantly lower in heart than liver and much higher in skeletal muscle mitochondria ([Figures 3A](#F3){ref-type="fig"} and [3B](#F3){ref-type="fig"}). Altogether, these results support a distinct profile for both MICUs and MCU protein expression in liver, heart, and skeletal muscle.

The high amount of MCU correlates directly with the fast ^45^Ca uptake in skeletal muscle. However, the lower amount of MCU in heart versus liver could not account for the faster ^45^Ca uptake at the submicromolar range in heart. Also, the \[Ca^2+^\]~c~ dependency was similar in heart and skeletal muscle (see slopes in [Figure 2D](#F2){ref-type="fig"}). To test whether the stoichiometry, i.e., the quantitative abundance of MICUs and MCU might determine the different mitochondrial Ca^2+^ uptake profiles in these tissues, we calculated for the three tissues in each mouse the protein ratios among MICU1, MICU2, and MCU ([Figures 3C](#F3){ref-type="fig"}--[3E](#F3){ref-type="fig"}) and then the ratio of the ^45^Ca uptake at low and high \[Ca^2+^\]~c~, which is higher when both threshold and cooperativity are low ([Figure 3F](#F3){ref-type="fig"}). Only the MICU1:MCU ratio showed a complementing pattern with the mitochondrial Ca^2+^ uptake phenotype ([Figures 3E](#F3){ref-type="fig"} and [3F](#F3){ref-type="fig"}). Indeed, both heart and muscle mitochondria, which displayed lesser threshold and cooperativity of mtCU activation than liver mitochondria ([Figure 3F](#F3){ref-type="fig"}), had a low MICU1:MCU ratio ([Figure 3E](#F3){ref-type="fig"}), whereas their MICU1:MICU2 ([Figure 3C](#F3){ref-type="fig"}) and MICU2:MCU ratios ([Figure 3D](#F3){ref-type="fig"}) were clearly opposite. Thus, the mitochondrial Ca^2+^ uptake behavior for a population of mitochondria within a tissue seems to be dictated by the relative abundance of MICU1 and MCU.

To test the relevance of other components of the mtCU in its \[Ca^2+^\]-dependent regulation, the protein abundance of another mtCU regulator, MICU3, as well as EMRE was evaluated in liver, heart, and muscle mitochondria ([Figure S2A](#SD1){ref-type="supplementary-material"}). MICU3 was detectable only in skeletal muscle mitochondria, and EMRE level followed the MCU expression profile, i.e., significantly higher levels in skeletal muscle than heart and liver mitochondria ([Figure S2B](#SD1){ref-type="supplementary-material"}). Thus, neither MICU3 nor EMRE correlated with the tissue-specific \[Ca^2+^\] dependence of the mtCU. The lack of a reliable antibody precluded quantification of MCUb, but this protein is devoid of a known Ca^2+^-binding motif. Recently, a MICU1 splice variant, MICU1.1, was identified specifically in skeletal muscle as a positive regulator of the mtCU in the entire physiological range of \[Ca^2+^\]~c~ ([@R30]) and so could have contributed to the high mtCU Ca^2+^ transport activity in skeletal muscle. Notably, both MICU1.1 and MICU1 are recognized by the MICU1 antibody used by [@R30] and us, and the two isoforms are undistinguishable in western blot due to their close molecular weight. Collectively, these data seem to indicate a role for the MICU1:MCU ratio in vivo in the physiological tissue-specific control of mitochondrial Ca^2+^ uptake.

MICU1:MCU Protein Expression Ratio Correlates Directly with MICU1 to MCU Association {#S5}
------------------------------------------------------------------------------------

An outstanding point remains whether the changes in MICU1 and MCU expression affect their association. Unfortunately, the lack of a reliable antibody for immunoprecipitation (IP) of endogenous MICU1 and MCU precluded co-IP experiments in mouse tissues. Therefore, co-IP of MCU-FLAG and varying amounts of MICU1-hemagglutin (HA) co-transfected to MICU1-knockout (KO) HEK cells was performed to establish different MICU1:MCU ratios. Based on the MCU-FLAG IP, increasing the MICU1 protein level (and so the MICU1:MCU ratio) led to an essentially linear increase in the MICU1:MCU ratio in the IP, indicating a direct correlation between the MICU1 to MCU expression and association ([Figures 3G](#F3){ref-type="fig"} and [3H](#F3){ref-type="fig"}). Furthermore, the MICU1-HA IP showed that the MCU bound per MICU1 is unchanged by different levels of MICU1 expression ([Figures 3G](#F3){ref-type="fig"}--[3I](#F3){ref-type="fig"}), suggesting that, in a broad range of MICU1 expression, MICU1 quantitatively binds MCU and some uniporter complexes do not have MICU1. To summarize, MCU pulled down MICU1 proportionally to its relative abundance whereas MICU1 at various expression levels pulled down steady amounts of MCU, suggesting that MICU1:MCU ratio controls a binary balance between uniporter complexes with or without MICU.

Because the quantitative association of MICU1 and MCU was testable only in vitro, we decided to also test the control of mitochondrial Ca^2+^ uptake by changes in expression of MICU1 and MCU in cell culture. To this end, we either overexpressed MCU or silenced MICU1 in HeLa cells, with both resulting in reduced MICU1/2:MCU ratio ([Figure S3A](#SD1){ref-type="supplementary-material"}). To test whether the increased abundance of mtCUs without MICU1 would decrease the mtCU's \[Ca^2+^\]~c~ threshold, we evaluated in intact cells \[Ca^2+^\]~c~ and \[Ca^2+^\]~m~ during store-operated Ca^2+^ entry when most mitochondria respond to the bulk \[Ca^2+^\]~c~ increase. Both MCU overexpression and MICU1 silencing accelerated the \[Ca^2+^\]~m~ rise as displayed by the shorter lag between the \[Ca^2+^\]~c~ and \[Ca^2+^\]~m~ increases ([Figure S3B](#SD1){ref-type="supplementary-material"}) and shorter coupling time (ctrl: 28.9 ± 1.7 s versus MCU: 21.5 ± 1.0 s; p \< 0.05). In addition, as revealed by \[Ca^2+^\]~m~ versus \[Ca^2+^\]~c~ plots, lower \[Ca^2+^\]~c~ was sufficient to trigger a \[Ca^2+^\]~m~ rise upon both MCU overexpression and MICU1 silencing ([Figure S3B, lower](#SD1){ref-type="supplementary-material"}). Thus, both MCU overexpression and MICU1 silencing cause lesser thresholding of the mtCU phenotype in intact HeLa cells.

To confirm the effect of the MICUs to MCU ratio more directly on mitochondrial Ca^2+^ uptake, we next measured the \[Ca^2+^\]~m~ in permeabilized cells using a ratiometric Ca^2+^ probe, furaFF. Compartmentalized furaFF displayed mitochondrial localization in permeabilized HeLa cells as shown by colocalization with TMRE or mitochondria-targeted GFP ([Figure S3C](#SD1){ref-type="supplementary-material"}). When Ca^2+^ was added, the increase in the furaFF ratio was abolished by RuRed ([Figure S3D](#SD1){ref-type="supplementary-material"}), validating that the compartmentalized furaFF signal reported \[Ca^2+^\]~m~. Cells overexpressing MCU displayed a significant elevation of their resting \[Ca^2+^\]~m~ compared to Ctrl, which was prevented by RuRed ([Figures S3D and S3F](#SD1){ref-type="supplementary-material"}). After a Ca^2+^ pulse (1.5 μM), a higher initial rate of RuRed-sensitive \[Ca^2+^\]~m~ rise was observed in MCU-overexpressing cells than in Ctrl cells ([Figure S3D](#SD1){ref-type="supplementary-material"}). Similar findings, i.e., an increased resting \[Ca^2+^\]~m~ and an accelerated \[Ca^2+^\]~m~ rise, were also observed in MICU1-silenced HeLa cells ([Figures S3E and S3F](#SD1){ref-type="supplementary-material"}). Together, these results suggest that decreasing the MICU1/2:MCU ratio lowers the apparent \[Ca^2+^\]~c~ threshold of the mtCU-mediated mitochondrial Ca^2+^ uptake in HeLa cells and thus support the idea that the threshold can be tuned also in vitro via shifting the balance between MCU complexes with and without MICU1. Among the three MICU isoforms, MICU3 is practically absent in HeLa cells, whereas both MICU1 and MICU2 showed similar changes in the above experiments, leaving the individual contribution of the two proteins unseparated.

Reprogramming Mitochondrial Ca^2+^ Uptake by Perturbing MICU1 in Heart and Liver {#S6}
--------------------------------------------------------------------------------

Could mitochondrial Ca^2+^ uptake be reprogrammed in liver and heart by perturbing the MICU:MCU ratio? To determine the effect of MICU1 overexpression in the heart, mice were infected by tail-vein injection with an adeno-associated virus of serotype 9 (AAV9), including either the luciferase gene or the human MICU1 gene (AAV9-Luc and AAV9-MICU1). Three weeks after injection, the human MICU1 mRNA level was increased in the heart of AAV9-MICU1 mice without a significant change in MCU, MICU2, and MCUb ([Figure 4A](#F4){ref-type="fig"}; [Table S1](#SD1){ref-type="supplementary-material"}). The increased MICU1 (but not MICU2 or MCU) protein expression was confirmed by immunoblotting ([Figure 4B](#F4){ref-type="fig"}). As to the quantitative relationship between MICU and MCU, the AAV9-MICU1 mouse heart displayed a 2.6-fold increase of the MICU1:MCU and a 1.3-fold augmentation of the MICU2:MCU ratio ([Figure S4A](#SD1){ref-type="supplementary-material"}). We then assessed the effect of MICU1 overexpression on the cardiac mitochondrial Ca^2+^ uptake. AAV9-MICU1 heart mitochondria took up less Ca^2+^ at submicromolar \[Ca^2+^\]~c~ but displayed faster Ca^2+^ clearance at ≥10 μM \[Ca^2+^\]~c~ compared to AAV9-Luc Ctrl mitochondria ([Figures 4C](#F4){ref-type="fig"}, [S4B](#SD1){ref-type="supplementary-material"}, and [S4C](#SD1){ref-type="supplementary-material"}). Moreover, no limitation in the ΔΨ~m~ was observed between AAV9-Luc and AAV9-MICU1 heart mitochondria to explain the Ca^2+^ uptake rate difference at high \[Ca^2+^\]~c~ ([Figure S4D](#SD1){ref-type="supplementary-material"}). Comparison of the initial mitochondrial Ca^2+^ uptake between heart versus liver and AAV9-Luc versus AAV9-MICU1 heart mitochondria showed a significantly higher threshold at low \[Ca^2+^\]~c~ and a significantly higher uptake at high \[Ca^2+^\]~c~ in AAV9-MICU1 heart mitochondria and liver mitochondria compared to normal heart mitochondria ([Figure 4C](#F4){ref-type="fig"}). It is worth noting that liver mitochondria displayed a greater uptake than MICU1-overexpressing heart mitochondria at high \[Ca^2+^\]~c~, which might be explained by the lower MCUb in liver (see mRNA in [Table S1](#SD1){ref-type="supplementary-material"}). Double logarithmic plot also revealed an increased cooperative activation in the AAV9-MICU1 heart mitochondria, as evidenced by the higher slope ([Figure 4D](#F4){ref-type="fig"}; 2.52 ± 0.08 in AAV9-MICU1 versus 1.88 ± 0.06 in AAV9-Luc; p \< 0.05). Thus, the in vivo strategy to perturb MICU1 shows that increasing the MICU1:MCU ratio in the heart led to transition to a liver-like mitochondrial Ca^2+^ uptake phenotype, meaning an increased threshold and cooperativity of the mtCU activation. This point is further supported by a complementary experiment, using in vivo silencing of MICU1 in liver, which demonstrated a lower \[Ca^2+^\]~c~ threshold and lesser positive cooperativity of mitochondrial Ca^2+^ uptake in association with the decrease in the MICU1:MCU ratio ([@R2]; [@R6]). Collectively, these results strongly support a specific and major role for the MICU1:MCU ratio and thus the relative abundance of MICU1-associated and MICU1-free uniporters in the tissue-specific regulation of mitochondrial Ca^2+^ uptake in mice.

Recently, MCU has been shown to be dispensable for baseline cardiac function but required for the fight-or-flight response ([@R14]; [@R16]). We wondered whether reprogramming of the mitochondrial Ca^2+^ uptake by MICU1 would affect cardiac physiology. AAV9-MICU1 and AAV9-Luc mice were subjected to echocardiography: we observed a significant decrease in both ejection fraction and fractional shortening (respectively 66% ± 3% versus 57% ± 2% and 36% ± 2% versus 29% ± 1%; AAV9-Luc versus AAV9-MICU1; p \< 0.05; n = 9--10), indicating a contractile impairment in the AAV9-MICU1 mice. These results suggest that the low MICU1 level in the heart is required to properly decode the cytoplasmic Ca^2+^ signals by the mitochondria ([Figure 4E](#F4){ref-type="fig"}) and to optimize contractile function.

DISCUSSION {#S7}
==========

Here, we report that the expression of MICU1 relative to MCU and, in turn, their association into the mtCU complex with or without MICU1 is central to the tissue-specific differences in mitochondrial Ca^2+^ uptake and Ca^2+^-stimulated oxidative metabolism phenotypes. Specifically, MICU1 to MCU stoichiometry encodes the differential \[Ca^2+^\] dependence between hepatic and cardiac mitochondria, contributing to the fundamental mechanism that allows rapid and highly effective propagation of each \[Ca^2+^\]~c~ spike to mitochondria in hepatocytes and a lesser mitochondrial response to individual \[Ca^2+^\]~c~ oscillations in mouse cardiomyocytes that beat continually at 400--600/min rate. Thus, our data unravel a mechanism that might be central to determining spike-to-spike versus slow spike integration modes of mitochondrial Ca^2+^ signaling ([Figure 4E](#F4){ref-type="fig"}).

Previous studies have documented differences between Ca^2+^ uptake by liver and heart mitochondria ([@R4]; [@R32]), which we systematically analyzed by recording \[Ca^2+^\] dependence under identical conditions for the two tissues. These studies demonstrated that heart mitochondria have lesser maximal Ca^2+^ uptake capacity and less steep non-linear \[Ca^2+^\] dependence than liver mitochondria. The difference in Ca^2+^ uptake capacity, which is also supported by electrophysiology ([@R9]), might result from the relatively high cardiac MCUb expression. As to the differential \[Ca^2+^\] dependence, we speculated that it is likely related to MICUs because only these mtCU components display EF hand extramitochondrial Ca^2+^-sensing modules. Indeed, we demonstrated that MICU1 protein is scarcely present in the heart. MICU2, which seems to contribute to the regulation of mtCU by forming dimers with MICU1 ([@R13]; [@R22]), showed less striking expression level differences between heart and liver. Strikingly, we could reproduce both cardiac- and liver-like \[Ca^2+^\] dependency patterns in model cells by altering the MICU1 to MCU stoichiometry. Also, by increasing MICU1, we could reprogram heart mitochondria to show a liver phenotype of \[Ca^2+^\] dependency, which led to a contractile dysfunction. Because the heart still expresses a very low level of MICU1 protein, it means that there are a few MCU complexes interacting with MICU1 in the heart, but the balance is strongly shifted toward the MICU1-free uniporters, resulting in a low-threshold mitochondrial Ca^2+^ phenotype. One could wonder whether different Ca^2+^ transporters and buffering systems in liver and heart could also explain the tissue specificity. However, our Ca^2+^ uptake experiments were specific for the mtCU (RuRed validation; inhibition of Ca^2+^ efflux). Thus, our results support that the relative abundance of MICU1 and MCU determines the proportion of mtCU with and without MICU1, which results in physiological differences in mitochondrial Ca^2+^ sensing.

The potential physiological and pathophysiological significance of the distinct \[Ca^2+^\] dependence in heart and liver is broad. In H9c2 cardiac myotubes that have little spontaneous activity, we have shown that even a single \[Ca^2+^\]~c~ spark can be propagated to an adjacent mitochondrion to evoke a \[Ca^2+^\]~m~ mark ([@R20]), and in rabbit, rat, and guinea pig myocytes that display 400 Hz \[Ca^2+^\]~c~ oscillations, beat-to-beat \[Ca^2+^\]~m~ responses have been documented ([@R1]; [@R17]; [@R27]; [@R29]). However, at the even higher beating frequency of mouse heart, suppressing the response to individual Ca^2+^ transients and integration of frequency fluctuations is practical to avoid mitochondrial Ca^2+^ overload. In mouse cardiomyocytes, which display a low MICU1 to MCU ratio and thus a low threshold and cooperativity of most of their uniporters, the very short \[Ca^2+^\]~c~ transients are associated with very small mitochondrial Ca^2+^ uptake that is integrated into frequency-modulated \[Ca^2+^\]~m~ steady-state shifts rather than \[Ca^2+^\]~m~ oscillations. By contrast, the high MICU1 and cooperative activation of mtCU in the liver favors delivery of each individual \[Ca^2+^\]~c~ spike to the mitochondria in hepatocytes ([@R6]). These differences are depicted in the schematic of [Figure 4E](#F4){ref-type="fig"}. Interestingly, heart mitochondria also display a higher NCLX level than liver mitochondria (data not shown), suggesting that higher mitochondrial Ca^2+^ efflux in heart may be required for preventing mitochondrial Ca^2+^ overload.

In summary, our work identifies the MICU1 to MCU ratio as a physiological regulator of the mitochondrial Ca^2+^ uptake phenotype in tissues, contributing to the tissue-specific decoding of \[Ca^2+^\]~c~ oscillations toward differentially regulating oxidative metabolism in liver and heart. In light of the recent description of mitochondrial disease linked to loss-of-function MICU1 mutations ([@R15]), the delicate balance of MICU1 and MCU likely is important in humans and in a variety of tissues, including nervous tissue and skeletal muscle.

EXPERIMENTAL PROCEDURES {#S8}
=======================

Detailed protocols are available in the Supplemental Experimental Procedures.

Animals {#S9}
-------

Mice were bred by homozygous intercross. Studies were done in accordance with the Thomas Jefferson University institutional review board guidelines. Female mice were used for the isolation of liver and heart mitochondria. For MICU1 overexpression, tail-vein injection was performed on male mice at 10 weeks old with 6 × 10^11^ genome copies (GCs)/mouse of AAV9-luciferase or AAV9-MICU1.

Heart, Skeletal Muscle, and Liver Mitochondria Isolation {#S10}
--------------------------------------------------------

Mice were euthanized by cervical dislocation. Heart, muscle, and liver mitochondria were isolated by differential centrifugations from the same mice.

Live-Cell Imaging and Fluorometric Measurements of Mitochondrial Ca^2+^ Uptake, Membrane Potential, and NADH {#S11}
------------------------------------------------------------------------------------------------------------

\[Ca^2+^\]~m~, \[Ca^2+^\]~c~, and ΔΨ~m~ were measured as described ([@R6]). NAD(P)H autofluorescence was monitored with excitation at 360 nm and emission at 450 nm, whereas \[Ca^2+^\]~c~was recorded simultaneously with rhod2 using 545 nm excitation and 580 nm emission. The mitochondrial NAD(P)H oxidation state was calibrated by applying 5 μM rotenone and 2 μM carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone (FCCP) at the end of each recording. Tg and CGP-37157 were present in all measurements.

Measurements of ^45^Ca Uptake by Isolated Mitochondria {#S12}
------------------------------------------------------

Mitochondria (250 μg/mL) were resuspended in intracellular medium (ICM) containing 2 μM Tg, 20 μM CGP-37157, and 10 μM EGTA. Mitochondria were energized by 1 mM malate/pyruvate at 37°C. Subsequently, suspensions were mixed with different amounts of ^45^Ca in the absence or presence of RuRed (3 μM). At 15-s and 30-s time points, 100-μL aliquots were stopped and ^45^Ca in the mitochondria was quantified as described ([@R6]). Free \[Ca^2+^\]~c~ was measured separately by fluorometric measurements using fura2 or furaFF.

Statistical Analysis {#S13}
--------------------

Data are expressed as mean ± SEM. Experiments were performed at least three times in duplicates or more. Statistical analysis was performed using the Student's t test, paired t test, or Mann-Whitney rank sum test when comparing two groups and ANOVA-1 followed by a Student-Newman-Keuls post hoc test for comparisons between multiple groups.
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![Cardiac Mitochondria Display Low-Threshold and Less Cooperative Activation of Ca^2+^ Uptake and Oxidative Metabolism Compared to Liver Mitochondria\
(A) Time courses of the mitochondrial clearance of the \[Ca^2+^\]~c~ rise upon addition of a 3 μM CaCl~2~ bolus (3Ca) in suspensions of liver (black) and heart (red) mitochondria, with and without RuRed (3 μM).\
(B) NAD(P)H autofluorescence level (expressed as a % by calibration; see Experimental Procedures) measured after a CaCl~2~ bolus of 3 or 30 μM (3Ca or 30Ca) in heart and liver mitochondria.\
(C) Mitochondrial clearance of \[Ca^2+^\]~c~ elevations induced by 50 μM CaCl~2~ addition.\
(D) ΔΨ~m~ measured with tetramethylrhodamine, methyl ester (TMRM). TMRM is used in de-quench mode; thus, the direction of polarization is downward. Note that heart mitochondria are the more polarized.\
(E) \[Ca^2+^\]~c~ dose response for the initial mitochondrial uptake of different Ca^2+^ boluses in mouse liver(black) and heart (red) mitochondria. The CaCl~2~ doses added were (in μM) 3, 5, 7, 10, 20, and 50 (n = 6 mice). A sigmoidal fit is displayed for each. x axis displays the measured peak \[Ca^2+^\]~c~.\
(F) Double logarithmic plot of the initial rates of Ca^2+^ uptake against the measured peak \[Ca^2+^\]~c~. Slope of each linear fit is indicated. Slopes calculated for both \[Ca^2+^\]~c~ clearance and ^45^Ca uptake ([Figure 2D](#F2){ref-type="fig"}) show similar tissue-specific pattern, but for unclear reasons, the absolute values are consistently higher for the \[Ca^2+^\]~c~ clearance.\
Data are presented as mean ± SEM; n = 3--4. See also [Figure S1](#SD1){ref-type="supplementary-material"}.](nihms930172f1){#F1}

![Liver, Heart, and Skeletal Muscle Mitochondria Show Distinct Regulation of Mitochondrial ^45^Ca^2+^ Uptake\
(A and B) Representative time courses of 45Ca^2+^ accumulation in isolated liver, heart, and skeletal mitochondria in presence or absence of RuRed (3 μM) after elevating \[Ca^2+^\]~c~ moderately (to 660 nM; A) or strongly (to 12 μM; B) by the addition of a pre-titrated Ca^2+^ bolus. Data are representative of n = 4 independent experiments with triplicates (mean ± SEM).\
(C) Mean values of the calculated ^45^Ca accumulated from traces similar to (A) and (B), against three ranges of free \[Ca^2+^\]~c~.\
(D) Double logarithmic plot of the RuRed-sensitive ^45^Ca accumulated against the free \[Ca^2+^\]~c~ 15 s after the addition. n = 4 independent experiments with triplicates.](nihms930172f2){#F2}

![MICU1 to MCU Protein Expression Ratio Correlates Directly with MICU1 to MCU Association to Control the Threshold and Cooperative Activation of Mitochondrial Ca^2+^ Uptake in Tissues\
(A) Representative immunoblotting in reducing conditions of MICU1, MICU2, MCU, and Hsp70 (mitochondrial loading control) in mice liver, heart, and skeletal muscle mitochondrial lysates.\
(B) Relative protein level of MICU1, MICU2, and MCU is displayed in the bar graph for each protein relative to Hsp70 and normalized to liver mitochondria.\
(C--E) Protein ratios of MICU1 to MICU2 (C), MICU2 to MCU (D), and MICU1 to MCU (E) calculated individually for each mouse.\
(F) Ratio between the Ca^2+^ accumulated at low \[Ca^2+^\]~c~ and at high \[Ca^2+^\]~c~ (from [Figure 2C](#F2){ref-type="fig"}) for each experiment. Mean ± SEM; n = 4; \*p \< 0.05.\
(G) HEK cells were co-transfected with MCU-FLAG and different levels of MICU1-HA to generate different MICU1 to MCU ratios. MCU-FLAG and MICU1 HA were co-immunoprecipitated either with specific FLAG-agarose beads or HA-agarose beads.\
(H) MICU1 to MCU ratio was calculated for the input and after the MCU-FLAG IP and normalized so that the values at the highest MICU1 to MCU ratio in the input were set to 1 for each experiment, indicated by the different shaped dot plots (n = 5). The linear fit indicates that the higher the MICU1 expression, the higher the MICU1 pulled down by MCU.\
(I) Similar calculations were performed as in (H) for the MICU1-HA IP (n = 3). The linear fit shows that the amount of MCU units bound to MICU1 is not changed by increasing the MICU1 expression.\
See also [Figures S2](#SD1){ref-type="supplementary-material"} and [S3](#SD1){ref-type="supplementary-material"}.](nihms930172f3){#F3}

![Increasing the MICU1 to MCU Ratio in the Heart Leads to a Liver-like mtCU Phenotype\
(A) mRNA level of human MICU1 (hMICU1) and mouse MICU1, MICU2, and MCU in AAV9-Luc (red) and AAV9-MICU1 (black) heart 3 weeks after the virus injection. The relative mRNA is reported using β-actin as a reference and normalized to the AAV9-Luc heart (mean ± SEM; n = 4; \*p \< 0.05 versus AAV9-Luc).\
(B) Protein expression of MICU1, MICU2, MCU, and Hsp70 in heart mitochondrial lysates from AAV9-Luc and AAV9-MICU1 3 weeks after injection. Level for each protein is shown relative to the loading control Hsp70 and normalized to AAV9-Luc heart mitochondria (mean ± SEM; n = 4; \*p \< 0.05).\
(C) Comparison of the initial mitochondrial Ca^2+^ uptake at low and high \[Ca^2+^\]~c~ in non-infected mouse heart and liver mitochondria and in AAV9-Luc and AAV9-MICU1 heart mitochondria. Data are expressed as a percentage of heart for liver mitochondria and of AAV9-Luc for AAV9-MICU1 mouse heart mitochondria (n = 4--6; \*p \< 0.05 versus respective heart).\
(D) Double logarithmic plot of the initial rates of Ca^2+^ uptake against the measured peak \[Ca^2+^\]~c~. Slope of each linear fit is indicated (n = 5).\
(E) Adaptation of mitochondrial decoding to the different temporal patterns of \[Ca^2+^\]~c~ signals through the balance between MICU1-associated and MICU1-free MCU in mouse liver and heart. In hepatocytes, the high MICU1 to MCU ratio and so more abundant MICU1-associated MCU complexes, which lead to both high threshold and cooperativity of their uniporters, allow rapid and highly effective propagation of each \[Ca^2+^\]~c~ spike to the mitochondria. In cardiomyocytes, which display a low MICU1 to MCU ratio and thus a higher abundance of MICU1-free MCU with low threshold and cooperativity, the \[Ca^2+^\]~c~ transients are integrated into a more continuous \[Ca^2+^\]~m~ increase, the magnitude of which depends on the frequency of \[Ca^2+^\]~c~ oscillations.\
See also [Figure S4](#SD1){ref-type="supplementary-material"} and [Table S1](#SD1){ref-type="supplementary-material"}.](nihms930172f4){#F4}

###### Highlights

-   Abundance of MICU1 relative to MCU directly reflects their association

-   Proportion of MICU1-bound MCU is limited by tissue-specific MICU1 availability

-   MICU1:MCU ratio affects mitochondrial Ca^2+^ uptake in liver and muscle

-   Liver-like MICU1:MCU ratio in heart leads to contractile dysfunction

###### In Brief

Paillard et al. report that the relative abundance of the pore-forming protein of the mitochondrial Ca^2+^ uniporter (MCU) and its Ca^2+^-sensing regulator (MICU1) define the proportion of MCU complexes with or without MICU1. This ratio is central to programming tissue-specific mitochondrial Ca^2+^ uptake phenotypes in the heart and liver.

[^1]: Lead Contact
